CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results Genetics Investing
Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis Biotech Investing
Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial Biotech Investing
Alphatec Announces FDA Clearance of its Automated SafeOp Neuromonitoring System to Address Significant Unmet Needs in Spine Surgery Medical Device Investing
Life Science Big News Roundup: Cardiovascular Performance Improvements Discovered in Lexaria’s TurboCBD(TM) Capsules Clinical Trail; NanoSphere Signs Definitive Licensing Agreement in Oregon; Biocure Signs MOU with Government of Uzbekistan and Gold-Dream LLC to Build Biosimilars Manufacturing Plant; Life Science Investing
Isodiol International Inc. Updates Frequently Asked Questions (FAQs) in Response to Recent Shareholder Inquiries Biotech Investing
